Ensuring our investments do good and do well.
At Zoic, we review over 1000 investment opportunities each year. Of those, we invest in only the most promising handful. Here are the traits our portfolio companies have in common:
· Transformative Technology
We seek rapid capital growth driven by disruptive innovation. We invest only in ventures where the underlying technological developments represent at least a 10x improvement in the standard of care.
· Verified and Transparent Methodology
We spend hundreds of hours of diligence analyzing each portfolio company. Our rigorous process ensures that each of our investments rest upon scientific mechanisms which are fully supported by published literature, independent trials, and personal observation.
· Strong and Defensible IP
We know that innovation translates into financial success only if the innovator can preserve and defend its intellectual property. We offer an extensive patent development suite, working with our portfolio companies to ensure that each is well-positioned with robust IP protection.
· Capable Leadership
We recognize that our portfolio companies need strong management as well as robust technology to succeed. We look for leadership teams with the combination of vision and experience necessary to succeed.
· Short Path to Regulatory Approval
Our goal is to provide investors with a speedy and substantial return on their capital. Accordingly, we invest only where we foresee initial regulatory approval on a short timeline, typically two to five years. For this reason, we favor technologies which benefit from expedited approval pathways such as 510(k).
· Clear Route to Exit
We recognize that our investors can only realize profits after a successful exit. Accordingly, we expect each portfolio company to have a well-defined exit strategy in place which will allow investors to extract full value at the appropriate moment.